ES546222A0 - Un procedimiento para preparar derivados de pirimidoisoqui- nolina - Google Patents

Un procedimiento para preparar derivados de pirimidoisoqui- nolina

Info

Publication number
ES546222A0
ES546222A0 ES546222A ES546222A ES546222A0 ES 546222 A0 ES546222 A0 ES 546222A0 ES 546222 A ES546222 A ES 546222A ES 546222 A ES546222 A ES 546222A ES 546222 A0 ES546222 A0 ES 546222A0
Authority
ES
Spain
Prior art keywords
pirimidoisokinoline
procedure
preparing derivatives
derivatives
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES546222A
Other languages
English (en)
Other versions
ES8604220A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838331228A external-priority patent/GB8331228D0/en
Priority claimed from GB848405776A external-priority patent/GB8405776D0/en
Priority claimed from GB848425791A external-priority patent/GB8425791D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES8604220A1 publication Critical patent/ES8604220A1/es
Publication of ES546222A0 publication Critical patent/ES546222A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES546222A 1983-11-23 1985-08-16 Un procedimiento para preparar derivados de pirimidoisoqui- nolina Expired ES8604220A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB838331228A GB8331228D0 (en) 1983-11-23 1983-11-23 Pyrimidoisoquinoline derivatives
GB848405776A GB8405776D0 (en) 1984-03-06 1984-03-06 Pyrimidoisoquinoline derivatives
GB848425791A GB8425791D0 (en) 1984-10-12 1984-10-12 Pyrimidoisoquinoline derivatives

Publications (2)

Publication Number Publication Date
ES8604220A1 ES8604220A1 (es) 1986-01-16
ES546222A0 true ES546222A0 (es) 1986-01-16

Family

ID=27262222

Family Applications (2)

Application Number Title Priority Date Filing Date
ES537928A Granted ES537928A0 (es) 1983-11-23 1984-11-23 Derivados de pirimidoisoquinolina
ES546222A Expired ES8604220A1 (es) 1983-11-23 1985-08-16 Un procedimiento para preparar derivados de pirimidoisoqui- nolina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES537928A Granted ES537928A0 (es) 1983-11-23 1984-11-23 Derivados de pirimidoisoquinolina

Country Status (17)

Country Link
US (1) US4673676A (es)
EP (1) EP0143001B1 (es)
KR (2) KR920008168B1 (es)
AR (1) AR243889A1 (es)
AT (1) ATE62484T1 (es)
AU (1) AU582554B2 (es)
CA (1) CA1232605A (es)
DE (1) DE3484420D1 (es)
DK (1) DK165789C (es)
ES (2) ES537928A0 (es)
FI (1) FI77034C (es)
GR (1) GR81006B (es)
HU (1) HU202528B (es)
IL (1) IL73586A (es)
NO (1) NO162019C (es)
PH (1) PH22068A (es)
SU (1) SU1512482A3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO162019C (no) * 1983-11-23 1989-10-25 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoiskinolinderivater.
US4661592A (en) * 1984-06-27 1987-04-28 G. D. Searle & Co. 4H-pyrimido[2,1-a]isoquinolin-4-one derivatives
JP5406215B2 (ja) 2008-01-25 2014-02-05 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー TNF−α合成の調節因子及びPDE4阻害剤としての三環系化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876788A (en) * 1970-08-27 1975-04-08 Burroughs Wellcome Co Heterocyclic compounds in the treatment of inflammatory of arthritic conditions
US4017625A (en) * 1975-08-01 1977-04-12 Pfizer Inc. Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
US4127720A (en) * 1977-09-21 1978-11-28 Bristol-Myers Company Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them
JPS59172472A (ja) * 1983-03-18 1984-09-29 Fujisawa Pharmaceut Co Ltd イソキノリン誘導体およびその塩類、それらの製造法ならびにそれらを有効成分とする抗アレルギ−剤
JPS59172490A (ja) * 1983-03-18 1984-09-29 Fujisawa Pharmaceut Co Ltd ピリミドイソキノリン誘導体およびその塩類、それらの製造法ならびにそれらを有効成分とする抗アレルギ−剤
NO162019C (no) * 1983-11-23 1989-10-25 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoiskinolinderivater.
US4661592A (en) * 1984-06-27 1987-04-28 G. D. Searle & Co. 4H-pyrimido[2,1-a]isoquinolin-4-one derivatives

Also Published As

Publication number Publication date
FI77034B (fi) 1988-09-30
HU202528B (en) 1991-03-28
NO844466L (no) 1985-05-24
FI77034C (fi) 1989-01-10
FI844406A0 (fi) 1984-11-09
PH22068A (en) 1988-05-20
HUT35674A (en) 1985-07-29
EP0143001B1 (en) 1991-04-10
CA1232605A (en) 1988-02-09
AU3540584A (en) 1985-05-30
DK536184A (da) 1985-05-24
EP0143001A3 (en) 1986-03-19
EP0143001A2 (en) 1985-05-29
KR850003538A (ko) 1985-06-20
ES8602786A1 (es) 1985-12-01
DK536184D0 (da) 1984-11-09
NO162019C (no) 1989-10-25
ES8604220A1 (es) 1986-01-16
DK165789C (da) 1993-06-14
IL73586A (en) 1988-12-30
SU1512482A3 (ru) 1989-09-30
ES537928A0 (es) 1985-12-01
AR243889A1 (es) 1993-09-30
KR920001673B1 (ko) 1992-02-22
NO162019B (no) 1989-07-17
US4673676A (en) 1987-06-16
IL73586A0 (en) 1985-02-28
ATE62484T1 (de) 1991-04-15
GR81006B (en) 1985-01-03
AU582554B2 (en) 1989-04-06
DK165789B (da) 1993-01-18
KR920008168B1 (ko) 1992-09-24
DE3484420D1 (en) 1991-05-16
FI844406L (fi) 1985-05-24

Similar Documents

Publication Publication Date Title
ES539563A0 (es) Un procedimiento para preparar derivados de fenilamino-mer- captoimidazol
ES540812A0 (es) Un procedimiento para la preparacion de nuevos derivados delaminometil-oxooxazolidinil-benceno
ES546916A0 (es) Un procedimiento para preparar derivados de guanina
ES538190A0 (es) Un procedimiento para preparar derivados de pirimidina
ES541229A0 (es) Un procedimiento para la preparacion de nuevos derivados delcromano
ES557808A0 (es) Un procedimiento para preparar derivados de octahidro(f) quinoleina
ES525886A0 (es) Un procedimiento para preparar derivados de propinilaminoisoxazol
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES543646A0 (es) Un procedimiento para la preparacion de derivados esteroida-les
ES529462A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
ES546061A0 (es) Un procedimiento para preparar un derivado de uridina
ES533673A0 (es) Procedimiento para la obtencion de un derivado de fenilsulfonilguanidina
ES532172A0 (es) Un procedimiento para la preparacion de derivados de pirimidona
ES527795A0 (es) Un procedimiento para preparar derivados de propinilaminotiazol
ES557566A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indol-diona
ES535392A0 (es) Un procedimiento para la preparacion de derivados de imidazobenzodiacepina
ES542185A0 (es) Un procedimiento para preparar derivados de dihidropiridina
ES546356A0 (es) Un procedimiento para la preparacion de nuevos derivados delacido tiazolilacetico
ES546574A0 (es) Procedimiento para preparar derivados de saframicina a
ES537098A0 (es) Un procedimiento para preparar derivados de tiadiazina
ES545777A0 (es) Un procedimiento para la preparacion de nuevos derivados de feniletanamina
ES529478A0 (es) Un procedimiento para preparar derivados de mitomicina
ES530855A0 (es) Un procedimiento para preparar derivados de benzotiazina
ES538697A0 (es) Un procedimiento para la preparacion de derivados de 1-normon-2-ilo

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519